Related Experiment Videos
High-dose antioxidant supplementation and cataract risk
1Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison, Wisconsin 53705-2397, USA.
Nutrition Reviews
|March 5, 2004
Summary
High-dose antioxidant supplements may slow lens opacity progression, but evidence is mixed. More research is needed to confirm benefits beyond multivitamins or diet for cataract prevention.
Area of Science:
- Ophthalmology
- Nutritional Science
- Clinical Trials
Background:
- Observational studies suggest antioxidant supplements may reduce cataract risk.
- Previous large trials have not shown benefits from high-dose antioxidant supplementation.
- The role of antioxidants in slowing cataract progression remains debated.
Purpose of the Study:
- To evaluate the effect of high-dose antioxidants on the progression of lens opacities.
- To compare findings with previous clinical trials on antioxidant supplementation.
- To assess the evidence for antioxidant efficacy in cataract prevention.
Main Methods:
- A recent clinical trial investigated the impact of high-dose antioxidant supplementation.
- Study design and participant criteria were detailed in the trial.
- Lens opacity progression was monitored as a primary outcome.
Main Results:
- The clinical trial observed a reduction in the progression of lens opacities with high-dose antioxidants.
- These findings contrast with results from several larger, earlier trials.
- No significant benefit was observed in those larger trials.
Conclusions:
- While one trial suggests a benefit, overall evidence for high-dose antioxidants slowing cataract progression is insufficient.
- Benefits may not exceed those from standard multivitamins or healthy diets.
- Further investigation is warranted to clarify the role of antioxidants in eye health.